MetLife, 5.875% Senior Notes due 11/21/2033 (MLG)

Accumulated OCI

-$18.74B

Quarterly · Period ending: · USD

MLG logo

MLG Accumulated OCI

Latest reported-$18.74B
MLG Quarterly Accumulated OCI (-$554.00M → -$18.74B)
High-resolution chart · PNG

MLG accumulated oci history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

MetLife, 5.875% Senior Notes due 11/21/2033 Accumulated OCI — Quarterly (USD)
Period endingAccumulated OCI (USD)
-18,743,000,000
-19,227,000,000
-18,084,000,000
-17,566,000,000
-19,859,000,000
-20,248,000,000
-21,186,000,000
-17,240,000,000
-20,736,000,000
-19,771,000,000
-19,242,000,000
-24,254,000,000
-20,386,000,000
-19,147,000,000
-22,621,000,000
-28,695,000,000
-17,372,000,000
-1,912,000,000
10,919,000,000
12,111,000,000
12,309,000,000
10,397,000,000
18,072,000,000
16,036,000,000
18,563,000,000
12,757,000,000
13,052,000,000
15,197,000,000
11,631,000,000
6,911,000,000
1,722,000,000
1,000,000,000
2,854,000,000
5,634,000,000
7,427,000,000
7,005,000,000
8,436,000,000
6,396,000,000
5,347,000,000
13,595,000,000
14,632,000,000
10,865,000,000
4,771,000,000
6,891,000,000
6,443,000,000
11,529,000,000
10,649,000,000
10,992,000,000
11,058,000,000
8,215,000,000
5,104,000,000
5,100,000,000
6,202,000,000
10,580,000,000
11,397,000,000
11,325,000,000
8,735,000,000
7,266,000,000
6,083,000,000
6,813,000,000
3,356,000,000
1,115,000,000
1,000,000,000
4,030,000,000
822,000,000
-1,191,000,000
-3,058,000,000
-2,234,000,000
-9,834,000,000
-15,358,000,000
-14,253,000,000
-7,540,000,000
-2,509,000,000
-1,028,000,000
1,078,000,000
56,000,000
-292,000,000
1,402,000,000
1,118,000,000
1,887,000,000
-991,000,000
590,000,000
1,912,000,000
1,874,000,000
3,081,000,000
2,156,000,000
2,956,000,000
2,794,000,000
1,717,000,000
3,444,000,000
2,792,000,000
3,009,000,000
3,306,000,000
2,312,000,000
2,007,000,000
2,114,000,000
1,469,000,000
842,000,000
1,673,000,000
1,834,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.